Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial (Q33596386)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37386436)
(P304) 11-14
(P407) (Q1860)
(P478) 57 Suppl
(P577) Tuesday, November 1, 1994
(P921) (Q269829)
(P1433) (Q1599804)
(P1476) "Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial" (language: en)
(P2093) J H Noseworthy
P C O'Brien
B G van Engelen
(P2860) (Q34260415)
(Q33494301)
(Q34271601)
(Q45796139)
(Q33475762)
(Q48694055)
(Q39760119)
(Q36885823)
(Q45831351)
(Q33446210)
(Q45835790)
(Q28285808)
(Q45839292)
(Q45839360)
(Q41336849)
(Q39171614)
(Q34549857)
(Q45044063)
(Q53871800)
(Q41722741)
(Q41731108)
(Q33520180)
(Q44385178)
(Q40082095)
(Q34427889)
(Q40021231)
(Q48257080)
(Q45794575)
(Q45861230)
(Q68204520)
(Q67906621)
(Q68196572)
(Q67973687)
(Q70564751)
(Q72453893)
(Q66905877)
(Q71048500)
(Q72681888)
(Q72690293)
(Q71487277)
(Q72716808)
(Q72382954)
(Q69891589)
(Q68981216)
(Q68090326)
(Q69293020)
(Q68705712)
(Q68033820)
other details
description scientific article

External Links